IRIS
SCORSETTI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.190
EU - Europa 2.342
AS - Asia 1.196
AF - Africa 366
SA - Sud America 24
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 17
Totale 16.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.105
SG - Singapore 686
FI - Finlandia 623
IE - Irlanda 530
NG - Nigeria 360
CN - Cina 340
DE - Germania 253
FR - Francia 226
IT - Italia 191
NL - Olanda 140
SE - Svezia 138
GB - Regno Unito 105
CA - Canada 79
TR - Turchia 47
IL - Israele 41
IN - India 39
BE - Belgio 29
AU - Australia 20
HK - Hong Kong 20
CZ - Repubblica Ceca 19
RU - Federazione Russa 18
AT - Austria 14
A2 - ???statistics.table.value.countryCode.A2??? 13
CL - Cile 13
PL - Polonia 10
GR - Grecia 8
NO - Norvegia 8
RO - Romania 8
BR - Brasile 7
ES - Italia 7
UA - Ucraina 6
IR - Iran 5
EU - Europa 4
JP - Giappone 4
PA - Panama 4
BD - Bangladesh 3
ID - Indonesia 3
NZ - Nuova Zelanda 3
ZA - Sudafrica 3
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
IQ - Iraq 2
MX - Messico 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
BG - Bulgaria 1
CH - Svizzera 1
KE - Kenya 1
KR - Corea 1
MD - Moldavia 1
PT - Portogallo 1
SI - Slovenia 1
VN - Vietnam 1
Totale 16.158
Salva come PNG Salva come JPEG
Città #
Wilmington 2.602
Chandler 2.153
San Mateo 1.014
Ann Arbor 720
Helsinki 623
Dublin 527
Singapore 472
Leawood 456
Lawrence 435
Princeton 435
Boardman 392
Benin City 360
Shanghai 311
Fairfield 261
Woodbridge 251
Paris 225
New York 218
Ashburn 204
Amsterdam 134
Milan 88
London 79
Seattle 79
Norwalk 71
Toronto 62
San Diego 52
Kocaeli 46
Phoenix 39
Santa Clara 39
Brussels 28
Falkenstein 23
Redwood City 23
Los Angeles 21
Monmouth Junction 19
Des Moines 18
Redmond 17
Brno 14
Pune 14
Munich 12
Vienna 11
Milwaukee 10
Beijing 9
Andover 8
Abbiategrasso 7
Clearwater 7
Frankfurt am Main 7
Genoa 7
Berlin 6
Cambridge 6
Collegeville 6
Hanover 6
Moscow 6
Las Vegas 5
Cupertino 4
Houston 4
Kemerovo 4
Prague 4
St Petersburg 4
São Paulo 4
Tappahannock 4
Taranto 4
Apo 3
Athens 3
Buffalo 3
Central District 3
Chandigarh 3
Durham 3
Eden Prairie 3
Jacksonville 3
Jakarta 3
La Canada Flintridge 3
New Berlin 3
Ottawa 3
Tokyo 3
Vaddangi 3
Augusta 2
Bagnara di Romagna 2
Belleville 2
Bogotá 2
Budapest 2
Chennai 2
Council Bluffs 2
Falls Church 2
Farmington 2
Guangzhou 2
Hamilton 2
Henderson 2
Lima 2
Livorno 2
Manchester 2
Melbourne 2
Meppel 2
Montreal 2
Mumbai 2
Niagara Falls 2
Nuremberg 2
Perth 2
Poznan 2
Raleigh 2
Rimini 2
Shenyang 2
Totale 12.764
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 96
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 88
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 77
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 75
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 73
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 67
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 66
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 61
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 60
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 60
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 59
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 58
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 58
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 58
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 58
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 58
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 57
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 57
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 57
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 56
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 55
Hypofractionated stereotactic radiation therapy in skull base meningiomas 55
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 55
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 55
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 55
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 55
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 55
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 55
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 54
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 54
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 53
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 53
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 53
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 53
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 53
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 53
Stereotactic radiotherapy with linear accelerators. Dosage considerations on collimators and photon beam energy 52
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 52
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 52
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 52
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 52
Organs at risk in lung SBRT 51
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 51
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 51
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 51
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 51
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 50
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 50
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 50
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 49
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 49
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 49
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 49
Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy 49
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 49
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 49
Long term follow up of Metastatic Epidural Spinal Cord Compression (MESCC) patients from breast cancer treated with surgery followed by radiotherapy. 49
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. 48
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 48
Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study 48
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 48
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 48
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 48
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series. 47
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 47
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 47
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 47
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in a observational study 47
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 47
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 47
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 47
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 46
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 46
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 46
Advantages of a system of positioning and localization made of thermo-conformable materials for irradiation of cervicofacial and encephalic lesions treated with stereotactic fractionated radiation 46
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 45
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 45
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. 45
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 45
Results of a feed-back learning process for RapidPlan knowledge based planning 45
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 45
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 45
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 45
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case. 45
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 45
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 45
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 45
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 45
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 44
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 44
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 44
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 44
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 44
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 44
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 44
Electrolyte abnormalities and side effects of zoledronate in patients with bone metastases 44
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 44
In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study. 44
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 44
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 44
Totale 5.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 0 0 0 0 0 56
2020/20214.698 40 51 63 45 17 1.475 604 382 992 521 15 493
2021/20222.192 98 21 31 545 13 10 87 367 195 235 511 79
2022/20236.181 940 180 540 709 548 512 9 518 1.168 530 458 69
2023/20243.155 202 380 727 113 94 303 128 140 131 60 353 524
2024/2025133 106 27 0 0 0 0 0 0 0 0 0 0
Totale 16.415